The utility of biomarkers in traumatic brain injury clinical management

被引：0
作者：
Ana Rodríguez-Rodríguez
Juan José Egea-Guerrero
机构：
[1] Virgen del Rocío University Hospital,Emergency Department
[2] IBIS/CSIC/University of Seville,NeuroCritical Care Unit
[3] Virgen del Rocío University Hospital,undefined
[4] IBIS/CSIC/University of Seville,undefined
来源：
Critical Care | / 20卷
关键词：
Traumatic Brain Injury; Severe Traumatic Brain Injury; Traumatic Brain Injury Patient; Glasgow Outcome Score; S100B Level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
[1]  
Thelin EP(2016)Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity Crit Care 20 285-7
[2]  
Jeppsson E(2016)S100B and neuron-specific enolase as mortality predictors in patients with severe traumatic brain injury Neurol Res 38 130-81
[3]  
Frostell A(2012)Multiple indicators model of long-term mortality in traumatic brain injury Brain Inj 26 1472-33
[4]  
Svensson M(2015)Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multi-marker approach in characterizing outcome Front Neurol 6 110-29
[5]  
Mondello S(2012)Role of S100B in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults Clin Chim Acta 24 228-5
[6]  
Bellander BM(2014)Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury Neurocrit Care 20 217-undefined
[7]  
Rodriguez-Rodriguez A(2004)S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients Neurol Res 26 440-undefined
[8]  
Egea-Guerrero JJ(undefined)undefined undefined undefined undefined-undefined
[9]  
Gordillo-Escobar E(undefined)undefined undefined undefined undefined-undefined
[10]  
Enamorado-Enamorado J(undefined)undefined undefined undefined undefined-undefined
1234